POINT BIOPHARMA GLOBAL INC's ticker is PNT and the CUSIP is 730541109. A total of 130 filers reported holding POINT BIOPHARMA GLOBAL INC in Q3 2023. The put-call ratio across all filers is 3.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,675,051 | -18.9% | 1,900,074 | +10.1% | 0.00% | 0.0% |
| Q2 2023 | $15,632,012 | +36.0% | 1,725,387 | +9.1% | 0.00% | +100.0% |
| Q1 2023 | $11,497,037 | +107168.5% | 1,581,435 | +7.6% | 0.00% | -50.0% |
| Q4 2022 | $10,718 | -99.9% | 1,470,260 | +16.4% | 0.00% | +100.0% |
| Q3 2022 | $9,759,000 | +7.9% | 1,262,598 | -5.0% | 0.00% | 0.0% |
| Q2 2022 | $9,047,000 | +62.2% | 1,328,543 | +89.9% | 0.00% | 0.0% |
| Q1 2022 | $5,576,000 | +60.4% | 699,683 | +12.7% | 0.00% | – |
| Q4 2021 | $3,476,000 | -11.6% | 620,875 | +21.4% | 0.00% | -100.0% |
| Q3 2021 | $3,934,000 | – | 511,618 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 2,312,523 | $18,431,000 | 4.36% |
| GREAT POINT PARTNERS LLC | 2,060,000 | $16,418,000 | 3.97% |
| RA Capital Management | 9,003,018 | $71,754,000 | 1.57% |
| JOHNSON & JOHNSON | 1,000,000 | $7,970,000 | 1.51% |
| BVF INC/IL | 3,367,826 | $26,842,000 | 1.07% |
| Boxer Capital, LLC | 2,500,000 | $19,925,000 | 1.02% |
| Sio Capital Management, LLC | 377,684 | $3,010,000 | 1.00% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,014,408 | $24,025,000 | 0.73% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 204,679 | $1,631,000 | 0.68% |
| Atom Investors LP | 60,103 | $479,000 | 0.22% |